Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Preaxia Health Care Payment Systems (PAXH) EBITDA (2019 - 2025)

Preaxia Health Care Payment Systems' EBITDA history spans 7 years, with the latest figure at -$115686.0 for Q4 2025.

  • On a quarterly basis, EBITDA fell 746.52% to -$115686.0 in Q4 2025 year-over-year; TTM through Nov 2025 was -$1.0 million, a 3109.06% decrease, with the full-year FY2025 number at -$79782.0, up 19.78% from a year prior.
  • EBITDA hit -$115686.0 in Q4 2025 for Preaxia Health Care Payment Systems, up from -$874906.0 in the prior quarter.
  • Over the last five years, EBITDA for PAXH hit a ceiling of -$4611.0 in Q2 2024 and a floor of -$874906.0 in Q3 2025.
  • Historically, EBITDA has averaged -$81034.1 across 5 years, with a median of -$40919.0 in 2023.
  • Biggest five-year swings in EBITDA: soared 88.69% in 2024 and later crashed 18808.71% in 2025.
  • Tracing PAXH's EBITDA over 5 years: stood at -$43655.0 in 2021, then fell by 3.29% to -$45092.0 in 2022, then dropped by 0.04% to -$45109.0 in 2023, then soared by 69.7% to -$13666.0 in 2024, then tumbled by 746.52% to -$115686.0 in 2025.
  • Business Quant data shows EBITDA for PAXH at -$115686.0 in Q4 2025, -$874906.0 in Q3 2025, and -$13463.0 in Q1 2025.